These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7878597)

  • 1. [Controlled randomized trials of pharmaceutic aids for smoking cessation. Results and perspectives].
    Said S; Berlin I; Puech AJ
    Therapie; 1994; 49(4):313-9. PubMed ID: 7878597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
    Rose JE; Herskovic JE; Behm FM; Westman EC
    Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking behavior on the first day of a quit attempt predicts long-term abstinence.
    Westman EC; Behm FM; Simel DL; Rose JE
    Arch Intern Med; 1997 Feb; 157(3):335-40. PubMed ID: 9040302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
    Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
    Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
    Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
    Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
    Schneider MP; van Melle G; Uldry C; Huynh-Ba M; Fallab Stubi CL; Iorillo D; Burnier M; Zellweger JP
    Nicotine Tob Res; 2003 Oct; 5(5):719-27. PubMed ID: 14577988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL; Jones L; Lancaster T; Fowler GH
    Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
    Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
    Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
    Foulds J
    Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Florek E; Piekoszewski W
    Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of the nicotine transdermal patch for smoking cessation.
    Wasley MA; McNagny SE; Phillips VL; Ahluwalia JS
    Prev Med; 1997; 26(2):264-70. PubMed ID: 9085397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.
    Le Houezec J
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking cessation interventions in clinical practice.
    Cornuz J
    Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user.
    Hajek P; McRobbie H; Gillison F
    Prev Med; 2007 Mar; 44(3):230-4. PubMed ID: 17207524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.